Keros Therapeutics Inc at Cowen Health Care Conference Transcript
My name's Tyler Van Buren, Senior Biotech Analyst here at TD Cowen. So for our next session, we have a fireside chat with Keros. It's my pleasure to introduce Jas Seehra, the CEO and co-founder -- or CEO and founder. Jas, privileged to have you here. Thank you for being here.
Thank you, Tyler. It's great to be here. It's wonderful seeing everybody in person.
Couldn't agree more. (Operator Instructions) But for those who are less familiar with the Keros story, Jas, perhaps you can just give them a brief background based upon your experience at Acceleron and why you decided to start Keros.
So I left Acceleron in 2010. And by that point, I think we had demonstrated on multiple occasions that the biology in this pathway translates faithfully from rodents all the way to humans, right? That the good, the bad, and the ugly
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
